RemeGen Co., Ltd. (SHA:688331)
China
· Delayed Price · Currency is CNY 48.90
+3.44 (7.57%)
May 13, 2025, 3:00 PM CST
RemeGen Market Cap
RemeGen has a market cap or net worth of 22.43 billion as of May 13, 2025. Its market cap has decreased by -5.38% in one year.
Market Cap
22.43B
Enterprise Value
24.42B
Revenue
1.91B
Ranking
n/a
PE Ratio
n/a
Stock Price
48.90
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has decreased from 28.53B to 22.43B, a decrease of -21.36%. That is a compound annual growth rate of -5.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 12, 2025 | 22.43B | 70.46% |
| Dec 31, 2024 | 13.16B | -53.43% |
| Dec 29, 2023 | 28.26B | -23.48% |
| Dec 30, 2022 | 36.93B | 18.81% |
| Dec 31, 2021 | 31.09B | -20.67% |
| Dec 31, 2020 | 39.18B | 37.36% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Jiangsu Hengrui Medicine | 335.80B |
| Shenzhen Mindray Bio-Medical Electronics | 270.90B |
| WuXi AppTec | 168.36B |
| Zhangzhou Pientzehuang Pharmaceutical., | 125.22B |
| Aier Eye Hospital Group | 119.56B |
| Sichuan Biokin Pharmaceutical | 112.28B |
| Shanghai United Imaging Healthcare | 112.08B |
| Yunnan Baiyao Group Co.,Ltd | 101.81B |